PRO DEX vs Avita Medical
PRO DEX and Avita Medical are similar in size: $77.5m and $71.6m of revenue in their latest fiscal years. PRO DEX grew faster (16.5% against 11.5%). PRO DEX kept more of each dollar of sales as profit: a net margin of 17.6% against -67.8%.
| Latest fiscal year | PRO DEXPDEX, 2026 | Avita MedicalRCEL, 2025 |
|---|---|---|
| Revenue | $77.5m | $71.6m |
| Revenue growth | 16.5% | 11.5% |
| Net income | $13.7m | −$48.6m |
| Operating margin | 16.8% | -59.4% |
| Net margin | 17.6% | -67.8% |
| Return on equity | 32.4% | — |
| Free cash flow | $6.8m | −$32.2m |
| Cash | $8.2m | $10.2m |
| Total debt | $21.7m | $43.0m |
| Debt to equity | 45.6% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $3.4m | — |
| Employees | 206 | 226 |
| Market value | $185m | $477m |
| Price vs our value range | Above our value range | — |
| Moat score | 70 (Strong) | 29 (Weak) |
| Insider trades, 12 months | 0 buys, 20 sales | 14 buys, 0 sales |